30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Forte Biosciences Inc (FBRX)

Track

The most recent insider trading activity occurred on December 30, 2025, with a BUY transaction by Chief Financial Officer Antony A. Riley. Prior to this, significant BUY transactions were also made by Antony A. Riley on November 21, 2024. Earlier in 2023, Paul A. Wagner executed multiple BUY transactions throughout the year.
Stock chart
Ticker: FBRX Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Riley Antony A
CHIEF FINANCIAL OFFICER
1 purchase — total 254,833 USD
Buy 30 Dec 2025
Value US$1,957,624.06 | Price 307.78 | Shares 98,438
Buy 21 Nov 2024
Value US$4,911,482.75 | Price 406.41 | Shares 9,910
Buy 18 Dec 2023
Value US$7,525.00 | Price 0.75 | Shares 10,000
Buy 14 Dec 2023
Value US$7,200.00 | Price 0.72 | Shares 10,000
Buy 13 Dec 2023
Value US$7,351.38 | Price 0.70 | Shares 10,520
Buy 12 Dec 2023
Value US$3,088.16 | Price 0.65 | Shares 4,776
Buy 11 Dec 2023
Value US$16,187.50 | Price 0.65 | Shares 25,000
Buy 8 Dec 2023
Value US$9,300.00 | Price 0.62 | Shares 15,000
Buy 7 Dec 2023
Value US$21,167.89 | Price 0.58 | Shares 36,203
Buy 22 Nov 2023
Value US$172.00 | Price 0.43 | Shares 400
Buy 20 Nov 2023
Value US$42.51 | Price 0.43 | Shares 100
Buy 20 Nov 2023
Value US$673.38 | Price 0.43 | Shares 1,566
Buy 20 Nov 2023
Value US$2,332.00 | Price 0.44 | Shares 5,300
Buy 16 Dec 2022
Value US$47,000.02 | Price 1.07 | Shares 44,024
Buy 15 Dec 2022
Value US$57,672.07 | Price 1.03 | Shares 55,976
Buy 14 Apr 2020
Value US$88,418.19 | Price 1.19 | Shares 74,301
Buy 2 Mar 2020
Value US$87,755.70 | Price 1.35 | Shares 65,149
Buy 30 May 2019
Value US$1,287.38 | Price 5.15 | Shares 250
Buy 30 May 2019
Value US$20,613.11 | Price 5.30 | Shares 3,890
Buy 30 May 2019
Value US$178,414.03 | Price 4.59 | Shares 38,860
Planned buy 28 May 2019
Value US$21,678.50 | Price 4.34 | Shares 5,000
Planned buy 28 May 2019
Value US$21,475.00 | Price 4.30 | Shares 5,000
Planned buy 24 May 2019
Value US$22,782.50 | Price 4.56 | Shares 5,000
Buy 19 Apr 2017
Value US$25,000.00 | Price 10.00 | Shares 2,500
Buy 19 Apr 2017
Value US$100,000.00 | Price 10.00 | Shares 10,000
Buy 19 Apr 2017
Value US$250,000.00 | Price 10.00 | Shares 25,000
Buy 19 Apr 2017
Value US$50,000.00 | Price 10.00 | Shares 5,000
Buy 19 Apr 2017
Value US$1,000,000.00 | Price 10.00 | Shares 100,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-02 2025-12-30 B Purchase
2.4
Riley Antony A

CHIEF FINANCIAL OFFICER

Officer
98,438 +23.6%
307.78
US$1,957,624 		98,438 +23.6% 307.78 US$1,957,624
2024-11-22 2024-11-21 B Purchase
2.4
Riley Antony A

CHIEF FINANCIAL OFFICER

Officer
9,910 -31.2%
406.41
US$4,911,483 		9,910 -31.2% 406.41 US$4,911,483
2023-12-20 2023-12-18 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
86,075 +47.8%
165.82
US$1,631,281 		86,075 +47.8% 165.82 US$1,631,281
2023-12-15 2023-12-14 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
10,000 +0.6%
0.72
US$7,200 		10,000 +0.6% 0.72 US$7,200
2023-12-15 2023-12-13 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
10,520 +0.6%
0.70
US$7,351 		10,520 +0.6% 0.70 US$7,351
2023-12-12 2023-12-12 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
4,776 +0.3%
0.65
US$3,088 		4,776 +0.3% 0.65 US$3,088
2023-12-12 2023-12-11 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
25,000 +1.4%
0.65
US$16,188 		25,000 +1.4% 0.65 US$16,188
2023-12-08 2023-12-08 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
15,000 +0.9%
0.62
US$9,300 		15,000 +0.9% 0.62 US$9,300
2023-12-08 2023-12-07 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
36,203 +2.1%
0.58
US$21,168 		36,203 +2.1% 0.58 US$21,168
2023-11-22 2023-11-22 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
400 +0.0%
0.43
US$172 		400 +0.0% 0.43 US$172
2023-11-22 2023-11-20 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
100 +0.0%
0.43
US$43 		100 +0.0% 0.43 US$43
2023-11-22 2023-11-20 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
1,566 +0.1%
0.43
US$673 		1,566 +0.1% 0.43 US$673
2023-11-22 2023-11-20 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
5,300 +0.3%
0.44
US$2,332 		5,300 +0.3% 0.44 US$2,332
2022-12-19 2022-12-16 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
44,024 +3.3%
1.07
US$47,000 		44,024 +3.3% 1.07 US$47,000
2022-12-19 2022-12-15 B Purchase
2.9
Wagner Paul A.

See Remarks

Executive Director
55,976 +4.4%
1.03
US$57,672 		55,976 +4.4% 1.03 US$57,672
2020-04-14 2020-04-14 B Purchase
2.6
Oliveira Steven Michael
Large shareholder
74,301 +2.7%
1.19
US$88,418 		74,301 +2.7% 1.19 US$88,418
2020-03-03 2020-03-02 B Purchase
2.6
Oliveira Steven Michael
Large shareholder
65,149 +2.4%
1.35
US$87,756 		65,149 +2.4% 1.35 US$87,756
2019-06-03 2019-05-30 B Purchase
2.7
Hasnain Faheem
250 +0.1%
5.15
US$1,287 		250 +0.1% 5.15 US$1,287
2019-06-03 2019-05-30 B Purchase
2.7
Hasnain Faheem
3,890 +1.6%
5.30
US$20,613 		3,890 +1.6% 5.30 US$20,613
2019-06-03 2019-05-30 B Purchase
2.7
Hasnain Faheem
38,860 +19.2%
4.59
US$178,414 		38,860 +19.2% 4.59 US$178,414
2019-05-29 2019-05-28 PP Planned purchase
Duvall Martin J

Chief Executive Officer

Executive Director
5,000 +58.1%
4.34
US$21,678 		5,000 +58.1% 4.34 US$21,678
2019-05-29 2019-05-28 PP Planned purchase
3.7
FOLETTA MARK G

EVP & Chief Financial Officer

Officer
5,000 +49.8%
4.30
US$21,475 		5,000 +49.8% 4.30 US$21,475
2019-05-29 2019-05-24 PP Planned purchase
GRUBER HARRY E

President, Science&Innovation

Executive Director
5,000 +105.4%
4.56
US$22,782 		5,000 +105.4% 4.56 US$22,782
2017-04-21 2017-04-19 B Purchase
Das Asha

SVP & Chief Medical Officer
2,500 +inf%
10.00
US$25,000 		2,500 +inf% 10.00 US$25,000
2017-04-21 2017-04-19 B Purchase
1.6
SCHIMMEL PAUL
10,000 +276.0%
10.00
US$100,000 		10,000 +276.0% 10.00 US$100,000
2017-04-21 2017-04-19 B Purchase
GRUBER HARRY E

President, Research & Devel

Executive Director
25,000 +6.4%
10.00
US$250,000 		25,000 +6.4% 10.00 US$250,000
2017-04-21 2017-04-19 B Purchase
3.7
FOLETTA MARK G

EVP & Chief Financial Officer
5,000 +inf%
10.00
US$50,000 		5,000 +inf% 10.00 US$50,000
2017-04-21 2017-04-19 B Purchase
2.7
Hasnain Faheem
100,000 +97.2%
10.00
US$1,000,000 		100,000 +97.2% 10.00 US$1,000,000
Explore more

More insider trading research around Forte Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America